
QIAGEN N.V. QGEN
Geschäftsbericht 2024
hinzugefügt 28.02.2026
QIAGEN N.V. Finanzkreislauf 2011-2026 | QGEN
Finanzkreislauf Jährlich QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 122 | 149 | 151 | 152 | 145 | 153 | 161 | 152 | 152 | 161 | 141 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 161 | 122 | 149 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
111 | $ 121.02 | 1.7 % | $ 36.8 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.96 | 4.71 % | $ 96.1 K | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 22.3 | -5.27 % | $ 234 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 28.14 | 2.07 % | $ 782 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 180.97 | 2.92 % | $ 8.97 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 14.14 | 2.56 % | $ 428 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
41.7 | $ 14.71 | -5.1 % | $ 1.91 B | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
IDEXX Laboratories
IDXX
|
103 | $ 650.0 | 2.28 % | $ 52.3 B | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
Illumina
ILMN
|
142 | $ 129.59 | 0.02 % | $ 20.6 B | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.14 | 1.88 % | $ 1.45 M | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 208.63 | 0.13 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
77.5 | $ 205.32 | 0.63 % | $ 146 B | ||
|
Organovo Holdings
ONVO
|
-82.8 K | - | -2.3 % | $ 19.4 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | $ 103.51 | 0.13 % | $ 19.5 B | ||
|
Bioventus
BVS
|
208 | $ 8.42 | -3.66 % | $ 527 M | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 9.65 | -6.26 % | $ 274 M | ||
|
DexCom
DXCM
|
134 | $ 73.39 | 0.42 % | $ 28.6 B | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
45.3 | - | -1.84 % | $ 15.3 M | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 110.81 | 1.94 % | $ 9.14 B | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.28 | 2.56 % | $ 1.03 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 281.11 | -0.69 % | $ 23.4 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 77.74 | -1.4 % | $ 5.25 B | ||
|
Guardant Health
GH
|
79.6 | $ 93.95 | 0.7 % | $ 11.8 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 177.49 | 2.0 % | $ 30.5 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 290.77 | -1.92 % | $ 26.6 B | ||
|
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 5.35 | 1.04 % | $ 495 M |